Back

Long-term cardiovascular risk in post-cardiac rehabilitation patients after one year follow-up using a smartphone application: 4-year post intervention follow-up of a randomized controlled trial

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Secondary Prevention and Rehabilitation Remote Patient Monitoring and Telehealth Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Associate Professor Pernille Lunde

OsloMet - Oslo Metropolitan University, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
Platelet-endothelial aggregation receptor 1 inhibits reendothelialization of injured arteries
Doctor T. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Comparing protocol-led lipid management with daily practice in post-myocardial infarction patients
Ms T. Van Trier (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Exercise-based cardiac rehabilitation for patients with atrial fibrillation receiving catheter ablation: associations with long-term clinical outcomes
Miss C. Fitzhugh (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Effect of a preconception lifestyle intervention on cardiometabolic outcomes in females at increased risk for gestational diabetes: a randomised controlled trial
Mr M. Sujan (Trondheim, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Secondary Prevention and Rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024
You may be interested in
thumbnail
Congress Session
How to implement a successful telemedicine program in heart failure
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
thumbnail
Congress Presentation
Remote patient monitoring with a digital health program: high compliance, retention, and engagement in a randomized study of patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources